Redwire Secures Additional $4M from NASA for Drug Development
Redwire announced that NASA has awarded the company an additional $4M to support new drug development investigations on the International Space Station using Redwire's Pharmaceutical In-space Laboratory technology. This additional funding expands an existing task order under a $25M, five-year indefinite-delivery/indefinite-quantity contract through NASA's In Space Production Applications program.
